NavidHeyrani

Associate

Irvine + 1.949.553.7579

Navid Heyrani's practice focuses on public and private M&A (both domestic and cross-border), corporate governance, and general corporate and securities matters.

Navid represents clients from a broad range of industries, including biopharmaceutical, medical device, pharmaceutical, technology, energy, telecommunications, and retail. Representative clients include Abbott Laboratories, Advantage Solutions, Ambry Genetics, Astellas Pharma US, the Internet Corporation for Assigned Names and Numbers (ICANN), Linear Technologies, Silver Chef Limited, Social Finance, Sumitomo Corporation, TDK Corporation, and Terumo Corporation.

Recent representations include Linear Technology's $14.8 billion sale to Analog Devices; TDK Corporation's $1.3 billion acquisition of InvenSense; Ambry Genetics' $1.0 billion sale to Konica Minolta; Advantage Solution's acquisitions of The Data Council, Quiverr Collective, and Upshot, Inc.; and ICANN in connection with the successful completion of the transition of the Internet Assigned Numbers Authority functions from the U.S. National Telecommunications and Information Administration to ICANN.

Experience

  • Furukawa Electric and Superior Essex global joint venture finalizedJones Day advised Furukawa Electric Co., Ltd. in its finalization of a global joint venture with Superior Essex Inc.
  • Lam Research completes $2 billion public offering of Senior NotesJones Day advised Lam Research Corporation, a global supplier of wafer fabrication equipment and services to the worldwide semiconductor industry, in connection with its underwritten public offering of $2 billion of Senior Notes, consisting of $750 million of 1.900% Senior Notes due 2030, $750 million of 2.875% Senior Notes due 2050, and $500 million of 3.125% Senior Notes due 2060.
  • Advantage Solutions acquires full-service brand, digital, and experiential agencyJones Day advised Advantage Solutions in its acquisition of a full-service brand, digital, and experiential agency.
  • Sumitomo Dainippon Pharma acquires late stage biopharma companies and forms alliance with Roivant Sciences Ltd. worth $3 billionJones Day advised Sumitomo Dainippon Pharma Co., Ltd. ("Sumitomo") in an acquisition of late stage biopharma companies and formation of alliance with Roivant Sciences Ltd.
  • Advantage Solutions acquires leading brand manager and marketing agencyJones Day advised Advantage Solutions in its acquisition of a leading brand manager and sales and marketing agency.
  • Western Digital sells IntelliFlash™ business to DataDirect Networks, Inc. (DDN®)Jones Day advised Western Digital Corp. in the sale of its IntelliFlash™ business to DataDirect Networks, Inc. (DDN®), a global leader in artificial intelligence (AI) and multi-cloud data management.
  • Ambry Genetics® acquires next-generation sequencing systemsJones Day advised Ambry Genetics® in its acquisition of next-generation sequencing systems.
  • Misonix acquires Solsys Medical, LLC for $109 millionJones Day advised Misonix, Inc. in its acquisition of Solsys Medical, LLC, a privately held regenerative medical company, in an all-stock transaction valued at approximately $109 million.
  • Western Digital acquires Kazan NetworksJones Day advised Western Digital Corporation (NASDAQ:WDC) in its acquisition of Kazan Networks Corp., a provider of industry leading NVMe™-over-Fabric (NVMe-oF) ASIC and adapter products for next-generation data center architectures.
  • Evidera acquires MedimixJones Day advised Evidera, a business unit of Pharmaceutical Product Development, LLC, in its acquisition of Medimix International, a global technology company providing real-world evidence (RWE) insights and information to the pharmaceutical, diagnostic, and medical device industries.
  • Lam Research completes $2.5 billion public offering of Senior NotesJones Day advised Lam Research Corporation, a global supplier of wafer fabrication equipment and services to the worldwide semiconductor industry, in connection with its underwritten public offering of $2.5 billion of Senior Notes, consisting of $750 million of 3.750% Senior Notes due 2026, $1.0 billion of 4.000% Senior Notes due 2029, and $750 million of 4.875% Senior Notes due 2049.
  • Cylance acquired by BlackBerry for $1.4 billionJones Day advised Cylance, an artificial intelligence and cybersecurity leader, in its $1.4 billion acquisition by BlackBerry Limited, plus the assumption of unvested employee incentive awards.
  • Advantage Solutions acquires Jun GroupJones Day advised Advantage Solutions on its acquisition of Jun Group, an industry-leading mobile video advertising company.
  • Syndicate of financial institutions provide $500 million credit facility to California developerJones Day represented a syndicate of financial institutions in connection with a $500 million unsecured credit facility, comprised of a $350 million revolving facility and $150 million term loan, provided to a California developer.
  • Social Finance acts as intermediary for Ventura County Project to Support ReentryJones Day represented Social Finance, Inc. in its role as intermediary for the Ventura County Project to Support Reentry, a collaborative pay for success project between Ventura County, Interface Children & Family Services, and Social Finance.
  • Ambry Genetics sold to joint venture formed by Konica Minolta and Innovation Network for up to $1.0 billionJones Day advised Ambry Genetics Corporation, a leading genetic testing corporation, in its sale to a newly formed joint venture between Konica Minolta, Inc. and Innovation Network Corporation of Japan for up to $1.0 billion (including earnouts).
  • Advantage Solutions acquires The Data CouncilJones Day advised Advantage Solutions in the acquisition of The Data Council, the leading provider of verified and standardized product data and images.
  • Advantage Solutions acquires QuiverrJones Day advised Advantage Solutions in its acquisition of Quiverr Collective, LLC.
  • TDK acquires InvenSense for $1.3 billionJones Day advised TDK Corporation in its $1.3 billion acquisition of InvenSense, Inc.
  • Linear Technology acquired by Analog Devices for $14.8 billionJones Day advised Linear Technology Corporation on its sale to Analog Devices, Inc.
  • We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.